Company profile

Ticker
SYK
Exchange
Website
CEO
Kevin A. Lobo
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
381239739

SYK stock data

(
)

Calendar

31 Jul 20
22 Sep 20
31 Dec 20

News

Quarter (USD) Jun 20 Mar 20 Sep 19 Jun 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Stryker earnings reports.

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
17 Sep 20 Srikant M. Datar Common Stock Payment of exercise Dispose F No 215.81 746 160.99K 18,345
17 Sep 20 Srikant M. Datar Common Stock Option exercise Aquire M No 53.6 3,000 160.8K 19,091
17 Sep 20 Srikant M. Datar Employee Stock Option granted 02/21/2012 Common Stock Option exercise Dispose M No 53.6 3,000 160.8K 1,945
6 Aug 20 Stryker Ronda E Common Stock Sell Dispose S No 186.5493 40,000 7.46M 0
6 Aug 20 Stryker Ronda E Common Stock Sell Dispose S No 185.9747 100,000 18.6M 6,809,068
1 Aug 20 Scannell Timothy J Common Stock Payment of exercise Dispose F No 193.3 1,872 361.86K 182,887
1 Aug 20 Scannell Timothy J Common Stock Option exercise Aquire M No 0 3,659 0 184,759
1 Aug 20 Scannell Timothy J RSU Common Stock Option exercise Dispose M No 0 3,659 0 3,659
31 Jul 20 Doliveux Roch Common Stock Buy Aquire P No 191.94 53 10.17K 22,070
31 Jul 20 Lobo Kevin Common Stock Sell Dispose S Yes 190.7966 25,855 4.93M 70,349
69.3% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1361 1326 +2.6%
Opened positions 133 103 +29.1%
Closed positions 98 188 -47.9%
Increased positions 537 500 +7.4%
Reduced positions 449 515 -12.8%
13F shares
Current Prev Q Change
Total value 397.42B 389.05B +2.2%
Total shares 260.15M 261.72M -0.6%
Total puts 1.11M 769.77K +44.5%
Total calls 1.35M 1.06M +27.5%
Total put/call ratio 0.8 0.7 +13.3%
Largest owners
Shares Value Change
N Price T Rowe Associates 29.2M $5.26B -2.7%
Vanguard 28.87M $5.2B -0.9%
BLK BlackRock 25.98M $4.68B -1.4%
Greenleaf Trust 20.96M $3.78B -0.9%
STT State Street 13.91M $2.51B +0.7%
Capital Research Global Investors 9.01M $1.62B -2.7%
BK Bank of New York Mellon 6.99M $1.26B -0.2%
BEN Franklin Resources 5.77M $1.12B +2.1%
Massachusetts Financial Services 5.62M $1.01B -9.6%
Geode Capital Management 4.72M $848.38M +3.2%
Largest transactions
Shares Bought/sold Change
FMR 1.5M -2.66M -64.0%
MKFCF Mackenzie Financial 1.24M +1.23M +11586.6%
Fisher Asset Management 2.38M +1.08M +82.8%
Wellington Management 1.09M +814.68K +296.2%
N Price T Rowe Associates 29.2M -804.14K -2.7%
MS Morgan Stanley 2.96M +725.68K +32.5%
JHG Janus Henderson 1.15M +606.36K +112.3%
Massachusetts Financial Services 5.62M -594.12K -9.6%
BlueSpruce Investments 1.71M +544.3K +46.7%
1832 Asset Management 657.61K -542K -45.2%

Financial report summary

?
Management Discussion
  • Our goal is to achieve sales growth at the high-end of the medical technology (MedTech) industry and maintain our long-term capital allocation strategy that prioritizes: (1) Acquisitions, (2) Dividends and (3) Share repurchases.
  • In 2019 we achieved reported net sales growth of 9.4%. Excluding the impact of acquisitions, sales grew 8.1% in constant currency. We reported net earnings of $2,083 and net earnings per diluted share of $5.48. Excluding the impact of certain items, we achieved adjusted net earnings of $3,139 and growth of 13.0% in adjusted net earnings per diluted share(1).
  • We continued our capital allocation strategy by investing $802 in acquisitions, paying $778 in dividends to our shareholders and using $307 for share repurchases.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Good
New words: approved, Committee, ERP, feature, fixed, gradual, mandatory, postponement, redeem, redemption, restoration, temporary, unpaid
Removed: achieved, body, clinical, cloud, complex, court, delivering, designed, direct, discount, dividend, evaluating, funding, greater, grew, hosting, improvement, permitted, service, software

Patents

APP
Utility
Systems and Methods for Robotic Soft Tissue Evaluation
17 Sep 20
A method of robotically evaluating soft tissue characteristics of a joint includes measuring, by a robotic device, information about a joint during a controlled range of motion manipulation of the joint; determining a motion limit of the joint, using the information about the joint measured during the controlled range of motion manipulation of the joint, wherein the motion limit is at least one of a displacement limit or a force limit of the joint; and replicating, using a joint positioner controlled by the robotic device, the controlled range of motion manipulation of the joint while introducing perturbations to the joint, wherein the replicated range of motion manipulation is controlled, at least in part, based on the motion limit.
APP
Utility
Robotic Surgical System and Methods Utilizing a Cutting Bur for Bone Penetration and Cannulation
17 Sep 20
Disclosed herein are techniques for preparation of a bone structure wherein a robotically controlled cutting bur is utilized for both milling the entry point at the outer cortical region and cannulation of the cancellous bone region for receipt of an implant.
APP
Utility
Spinal Implant And Methods Of Use Thereof
17 Sep 20
A spinal rod connector includes first and second arm assemblies and a fastener.
APP
Utility
Polyaxial Screwdriver For a Pedicle Screw System
17 Sep 20
A polyaxial screwdriver for inserting a bone screw in a vertebra.
APP
Utility
Orthopedic Implant And Methods Of Implanting And Removing Same
17 Sep 20
Illustrative embodiments of orthopedic implants and methods for surgically repairing hammertoe are disclosed.